Inhaled Steroids Linked to Worsened Sickle Cell Disease Markers
A 48-week randomised trial found that inhaled mometasone was associated with increased soluble VCAM-1 levels in adults with sickle cell disease without asthma, raising concerns about long-term treatment safety.







